Company
United StatesPublic company, NYSE: SNNSmith & Nephew Inc (NYSE: SNN), Memphis, TN – FDA Inspections
Inspection records and compliance data for Smith & Nephew Inc in Memphis, Tennessee. 1 FDA inspection on record, last inspected June 07, 2011. Publicly traded as NYSE: SNN.
Company Profile
This profile covers Smith & Nephew Inc based in Memphis, Tennessee, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected June 7, 2011.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 7, 2011 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 728742 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Veterans Affairs Medical Center / James H. Quillen Campus
Csl Plasma Inc
Laurie A. Harris-Ford, MD
Blood Assurance, Inc.
DCI Donor Services/dba Tennessee Donor Services
Natasha E. Ballard, M.D.
DCI Donor Services dba Tennessee Donor Services (Tri-Cities)
Gentleman Orthopedic Solutions LLC
Baptist Memorial Hospital-Memphis Division of Transfusion Medicine
Tennessee Valley HealthCare System
Company Information
Name
Smith & Nephew Inc
Stock ticker
SNN
Exchange
NYSE
Share price
$32.03
Market cap
$13.4B
Price as of
November 6, 2026
FEI Number
1000524858
Address
3303 E Holmes Rd, Memphis, Tennessee 38118, United States
Country
United States
ID: d8fe7493-840a-4250-912a-2adf6152adb2